Browsing by Subject "EGFR TKI resistance"
Now showing items 1-1 of 1
-
Nanotechnology – a robust tool for fighting the challenges of drug resistance in non-small cell lung cancer
( Beilstein-Institut Zur Forderung der Chemischen Wissenschaften , 2023 , Article)Genomic and proteomic mutation analysis is the standard of care for selecting candidates for therapies with tyrosine kinase inhibitors against the human epidermal growth factor receptor (EGFR TKI therapies) and further ...